RXO Tops Q3 Estimates With $0.09 Adjusted EPS as EBITDA Hits $51M
RXO has more than doubled off its 52-week low of $10.425.
Summary
RXO posted Q3 adjusted EPS of $0.09, beating the $0.07 IBES estimate, with adjusted EBITDA of $51 million at a 2.7% margin and adjusted net income of $16 million, on revenue of $1.9B. GAAP EPS was $0.02. The beat is a modest improvement over the Q2 adjusted EPS of $0.06 reported in August, when revenue jumped 25% year over year to $1.8B. The bigger story remains the pending $30.25-per-share cash-and-stock acquisition by C.H. Robinson announced October 5, which anchors the stock near deal value rather than on quarterly results.
At the time of this announcement, RXO was trading at $27.60 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $4.6B. The 52-week trading range was $10.43 to $29.90. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.